170 related articles for article (PubMed ID: 3621594)
1. Comparison of N-acetyl-beta-glucosaminidase and albuminuria with clinical finding of microangiopathy in type I diabetes mellitus.
Skrha J; Perusicová J; Stolba P; Stibor V; Páv J
Clin Chim Acta; 1987 Jul; 166(2-3):135-41. PubMed ID: 3621594
[TBL] [Abstract][Full Text] [Related]
2. N-Acetyl-beta-D-glucosaminidase levels and diabetic microangiopathy.
Whiting PH; Ross IS; Borthwick LJ
Clin Chim Acta; 1979 Oct; 97(2-3):191-5. PubMed ID: 487603
[TBL] [Abstract][Full Text] [Related]
3. Comparison of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase activities for evaluation of microangiopathy in diabetes mellitus.
Shimojo N; Kitahashi S; Naka K; Fujii A; Okuda K; Tanaka S; Fujii S
Metabolism; 1987 Mar; 36(3):277-80. PubMed ID: 2881186
[TBL] [Abstract][Full Text] [Related]
4. [Albuminuria and N-acetyl-beta-glucosaminidase activity in a prospective study of type I diabetics].
Skrha J; Sperl M; Stolba P; Hilgertová J; Stibor V
Vnitr Lek; 1993 Jul; 39(7):699-705. PubMed ID: 8372466
[TBL] [Abstract][Full Text] [Related]
5. Serum and urinary activities of beta-N-acetylglucosaminidase and beta-glucuronidase in diabetic patients.
Perdichizzi G; Cucinotta D; Saitta A; Cavalieri A; Squadrito G
Acta Diabetol Lat; 1983; 20(3):257-64. PubMed ID: 6637327
[TBL] [Abstract][Full Text] [Related]
6. Elevated N-acetyl-β-d-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study.
Lee M; Hong N; Lee YH; Kang ES; Cha BS; Lee BW
J Diabetes Complications; 2018 Aug; 32(8):777-783. PubMed ID: 29980431
[TBL] [Abstract][Full Text] [Related]
7. Urinary N-acetyl-beta-D-glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control.
Watts GF; Vlitos MA; Morris RW; Price RG
Diabete Metab; 1988; 14(5):653-8. PubMed ID: 3234588
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl-beta-glucosaminidase and albuminuria in normal and diabetic pregnancies.
Skrha J; Perusicová J; Sperl M; Bendl J; Stolba P
Clin Chim Acta; 1989 Jul; 182(3):281-7. PubMed ID: 2766552
[TBL] [Abstract][Full Text] [Related]
9. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy].
Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037
[TBL] [Abstract][Full Text] [Related]
10. Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria.
Watanabe Y; Nunoi K; Maki Y; Nakamura Y; Fujishima M
Clin Nephrol; 1987 Nov; 28(5):227-31. PubMed ID: 3322619
[TBL] [Abstract][Full Text] [Related]
11. Serum and urine N-acetyl-beta-D-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabetics.
Whiting PH; Ross IS; Borthwick L
Clin Chim Acta; 1979 Mar; 92(3):459-63. PubMed ID: 436284
[TBL] [Abstract][Full Text] [Related]
12. Urinary N-acetyl-beta-glucosaminidase activity in type I diabetes mellitus.
Jones AP; Lock S; Griffiths KD
Ann Clin Biochem; 1995 Jan; 32 ( Pt 1)():58-62. PubMed ID: 7762951
[TBL] [Abstract][Full Text] [Related]
13. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
Melosi A; Ricci F
Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
[TBL] [Abstract][Full Text] [Related]
14. N-Acetyl-beta-D-glucosaminidase levels and the onset of diabetic microangiopathy.
Whiting PH; Ross IS; Borthwick LJ
Ann Clin Biochem; 1983 Jan; 20 Pt 1():15-9. PubMed ID: 6838142
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular proteinuria and microalbuminuria in diabetic patients.
Gibb DM; Tomlinson PA; Dalton NR; Turner C; Shah V; Barratt TM
Arch Dis Child; 1989 Jan; 64(1):129-34. PubMed ID: 2923463
[TBL] [Abstract][Full Text] [Related]
16. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients].
Hirai M; Nakano H; Oba K; Metori S
Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372
[TBL] [Abstract][Full Text] [Related]
17. Urinary N-acetyl-beta-D-glucosaminidase in children with diabetes as an early marker of diabetic nephropathy.
Abdel Shakour S; el-Hefnawy H; el-Yamani MY; Azmi Y
East Mediterr Health J; 2002 Jan; 8(1):24-30. PubMed ID: 15330557
[TBL] [Abstract][Full Text] [Related]
18. [Urinary and serum N-acetyl-beta-D-glucosaminidase (NAG) activities in clinical significance].
Kitahashi S; Saeki S; Shimojo N; Naka K; Okuda K; Kohno M
Rinsho Byori; 1986 Jun; 34(6):687-93. PubMed ID: 3747209
[No Abstract] [Full Text] [Related]
19. Effect of exercise on urinary N-acetyl-beta-D-glucosaminidase activity and albumin excretion in children with type I diabetes mellitus.
Brouhard BH; Allen K; Sapire D; Travis LB
Diabetes Care; 1985; 8(5):466-72. PubMed ID: 4053933
[TBL] [Abstract][Full Text] [Related]
20. Urinary N-acetyl-beta-D-glucosaminidase activity does not predict development of diabetic nephropathy.
Agardh CD; Tallroth G; Hultberg B
Diabetes Care; 1987; 10(5):604-6. PubMed ID: 3677979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
